Document Detail


Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA.
MedLine Citation:
PMID:  16472793     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Dendritic cell (DC) vaccination with the use of total tumor RNA provides the potential to generate a polyclonal immune response to multiple known and unknown tumor antigens without HLA restriction. Our study evaluated this approach as potential immunotherapy for patients with hepatocellular carcinoma (HCC). Immature DCs generated from peripheral blood mononuclear cells of patients with HCC were transfected with HepG2-GFP (HepG2 cells transfected stably with plasmid pEGFP-C3) cells total RNA. Transfected, matured DCs were used to stimulate autologous T cells. Results revealed that DCs transfected with HepG2-GFP cells total RNA expressed EGFP when observed by flow cytometry. Compared with those before transfection, the expressions of membrane molecules were increased dramatically, and interleukin-12p70 release in the supernatant was elevated significantly. Specific T cells generated by DCs transfected with HepG2-GFP total RNA recognized HLA-matched HepG2 cell lines specifically. These findings indicate that these RNA-transfected DCs successfully generate specific T cells that specifically recognize HCC cells. Total tumor RNA-pulsed DCs may have potential as an adjuvant immunotherapy for patients with HCC.
Authors:
Liwang Zhang; Hongmei Zhang; Wenchao Liu; Hui Wang; Jun Jia; Xiaoming Si; Jun Ren
Related Documents :
12589163 - Dendritic cells exposed to nacystelyn are refractory to maturation and promote the emer...
9686593 - Dendritic cells interact directly with naive b lymphocytes to transfer antigen and init...
18830243 - Oligopotent stem cells are distributed throughout the mammalian ocular surface.
Publication Detail:
Type:  Journal Article     Date:  2006-02-10
Journal Detail:
Title:  Cellular immunology     Volume:  238     ISSN:  0008-8749     ISO Abbreviation:  Cell. Immunol.     Publication Date:  2005 Nov 
Date Detail:
Created Date:  2006-02-28     Completed Date:  2006-04-13     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  1246405     Medline TA:  Cell Immunol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  61-6     Citation Subset:  IM    
Affiliation:
Center of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antigens, CD / immunology
Carcinoma, Hepatocellular / immunology*,  therapy
Dendritic Cells / immunology*
Enzyme-Linked Immunosorbent Assay
Flow Cytometry
HLA-A2 Antigen / immunology
Humans
Immunophenotyping
Immunotherapy, Adoptive / methods*
Interferon-gamma / immunology
Interleukin-12 / immunology
K562 Cells
Liver Neoplasms / immunology*,  therapy
RNA, Neoplasm / genetics
T-Lymphocyte Subsets / immunology
T-Lymphocytes, Cytotoxic / immunology*
Transfection
Chemical
Reg. No./Substance:
0/Antigens, CD; 0/HLA-A2 Antigen; 0/RNA, Neoplasm; 187348-17-0/Interleukin-12; 82115-62-6/Interferon-gamma

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Potentiation of humoral immune response and activation of NF-kappaB pathway in lymphocytes in experi...
Next Document:  Naproxen-induced oxidative stress in the isolated perfused rat liver.